From: Prohibitin: targeting peptide coupled to ovarian cancer, luteinization and TGF-β pathways
Parameters | Group | F (P) | |||
---|---|---|---|---|---|
Control | Benign | Borderline | Malignant | ||
Intensity (Mean ± SD) | 2.2 ± 0.6 | 2.0 ± 0.0 | 2.6 d ±0.5 | 3.0 d ±0.0 | 0.001* |
% (Mean ± SD) | 69.3 ± 10.2 | 66.3 ± 16.0 | 85.6 d ±9.0 | 96.3 d ±3.9 | 0.001* |
Score (Mean ± SD) | 147.8 ± 43.5 | 132.5 ± 31.9 | 226.7 d ±64.4 | 288.8 d ±11.8 | 0.001* |